0001562180-24-002595.txt : 20240312
0001562180-24-002595.hdr.sgml : 20240312
20240312162036
ACCESSION NUMBER: 0001562180-24-002595
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kiernan Matthew
CENTRAL INDEX KEY: 0001993183
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39834
FILM NUMBER: 24742357
MAIL ADDRESS:
STREET 1: 500 PRINCIPIO PARKWAY WEST
STREET 2: SUITE 400
CITY: NORTH EAST
STATE: MD
ZIP: 21901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clene Inc.
CENTRAL INDEX KEY: 0001822791
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 852828339
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
BUSINESS PHONE: 801-676-9695
MAIL ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
FORMER COMPANY:
FORMER CONFORMED NAME: Chelsea Worldwide Inc.
DATE OF NAME CHANGE: 20200827
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-03-11
false
0001822791
Clene Inc.
CLNN
0001993183
Kiernan Matthew
6550 SOUTH MILLROCK DRIVE
SUITE G50
SALT LAKE CITY
UT
84121
true
false
false
false
false
Stock Options (Right to buy)
0.44
2024-03-11
4
A
false
29481.00
0.00
A
2034-03-11
Common Stock
29481.00
29481.00
D
This option was granted on March 11, 2024 as an option for 29,481 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant.
/s/ Jerry Miraglia POA
2024-03-12